Abstract
Recent interest in the role of taurine in the heart stems from the observation that cats fed a taurine deficient diet develop a cardiomyopathy1. This condition is reversible, as evidenced by the restoration of normal cardiac function upon dietary supplementation with taurine2. These studies have accelerated the search for a physiological function for taurine. Although several theories of taurine action have been proposed, none adequately accounts for all of the multiple properties and actions of taurine. Therefore, this review will address both the strengths and weaknesses of the present proposals, including the possibility that taurine may exhibit multiple physiological roles in the heart.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
P.D. Pion, M.D. Kittleson, Q.R. Rogers and J.G. Morris, Myocardial failure in cats associated with low plasma taurine: A reversible cardiomyopathy, Science 237:764–768 (1987).
P.D. Pion, M.D. Kittleson, N.L. Skiles, Q.R. Rogers, and J.G. Morris, Taurine deficiency myocardial failure: incidence and relation to tissue taurine concentration, this book (1992).
W.O. Read and J.D. Welty, Effect of taurine on epinephrine and digoxin induced irregularities of the dog heart, J. Phamiacol. Exp. Therap. 139:283–289 (1963).
W.O. Read and J.D. Welty, Taurine as a regulator of cell potassium in the heart, in: “Electrolytes and Cardiovascular Diseases,” E. Bajusz, ed, S. Karger, Basel/New York, 70–85 (1965).
E.I. Chazov, L.S. Malchikova, N.V. Lipina, G.B. Asafov and V.N. Smirnov, Taurine and electrical activity of the heart, Circ. Res. 34/35 SIII:III-11–III-21 (1974).
G.X. Wang, J. Duan, S. Zhou, P. Li and Y. Kang, Antiarrhythmic action of taurine, this book (1992).
K. Takahashi, J. Azuma, N. Awata, A. Sawamura, S. Kishomoto, T. Yamagami, T. Kishi, H. Harada and S.W. Schaffer, Protective effect of taurine on the irregular beating pattern of cultured myocardial cells induced by high and low extracellular calcium ion,J Mol. Cell CardioL 20:397–403 (1988).
N. Lake, M. de Roode and S. Nattel, Effects of taurine depletion on rat cardiac electrophysiology: In vivo and in vitro studies, Life Sci. 40:997–1005 (1987)..
J. Dietrich and J. Diacono, Comparison between ouabain and taurine effects on isolated rat and guinea-pig hearts in low calcium medium, Life Sci. 10:499–507 (1971).
S.W. Schaffer, J. Chovan and R.F. Werkuran, Dissociation of cyclic AMP changes and myocardial contractility in taurine-perfused rat heart, Biochem. Biophys. Res. Commun. 81:248–253 (1978).
J.P. Chovan, E.C. Kulakowski, S. Sheakowski and S.W. Schaffer, Calcium regulation by the low-affinity taurine binding sites of cardiac sarcolemma, Mol. PharmacoL 17:295–300 (1980).
M. Endoh, K. Ohkubo, H. Kushida and T. Hiramoto, Modulation of myocardial contractility by taurine: Absence of its interactions with the effects of low [Ca2+]o, verapamil, Bay K 8644, and a -and ß-adrenoceptor agonists in the rabbit papillary muscle, in: “Taurine and the Heart,” H. Iwata, J.B. Lombardini and T. Segawa, eds, Kluwer Academic Publishers, Boston/ Dordrecht/London, 51–73 (1989).
J.C. Khatter, P.L. Soni, R.J. Hoeschen, L.E. Alto and N.S. Dhalla, Subcellular effects of taurine on guinea pig heart, in:The Effects of Taurine on Excitable Tissues,“ S.W. Schaffer, S.I. Baskin and J.J. Kocsis, eds, Spectrum Press, New York, 281–293 (1981).
R. Bandinelli, F. Franconi, A. Giotti, F. Martini, G. Moneti, I. Stendardi and L. Zilletti, The positive inotropic effect of taurine and calcium and the levels of taurine in ventricular strips, Br. J. Phamiacol. 67:115–116P (1981).
A. Sawamura, J. Azuma, H. Harada, II. Hasegawa, K. Ogura, N. Sperelakis and S. Kishimoto, Protection by oral pretreatment with taurine against the negative inotropic effects of low-calcium medium on isolated perfused chick heart, Cardiovasc. Res. 27:620–626 (1983).
S.W. Schaffer, J. Kramer and J.P. Chovan, Regulation of calcium homeostasis in the heart by taurine, Fed. Proc. 39:2691–2694 (1980).
F. Franconi, F. Martini, I. Stendardi, R. Matucci, L. Zilletti and A. Giotti, Effect of taurine on calcium levels and contractility in guinea-pig ventricular strips, Biochem. PharmacoL 31:3181–3185 (1982).
M.S. Mozaffari, B.H. Tan, M.A. Lucia and S.W. Schaffer, Effect of drug-induced taurine depletion on cardiac contractility and metabolism, Biochem. Phamiacol. 35:985–989 (1986).
S.W. Schaffer, S. Allo and M. Mozaffari, Potentiation of myocardial ischemic injury by drug-induced taurine depletion, in: “The Biology of Taurine,” R.J. Huxtable, F. Franconi and A. Giotti, eds, Plenum Press, New York/London, 151–158 (1987).
N. Lake, J.B. Splawinski, C. Juneau and J.L. Rouleau, Effects of taurine depletion on intrinsic contractility of rat ventricular papillary muscles, Can. J. PhysioL Phammcol. 68:800–806 (1990).
J. Azuma, H. Katsume, T. Kagoshima, K. Furukawa, N. Awata, T. Ishiyama, T. Yamagami, H. Ishikawa, H. Iwata, S. Kishimoto and Y. Yamamura, Clinical evaluation of taurine in congestive heart failure-A double blind comparative study using CoQ10 as a control drug, in: “Taurine and the Heart,” H. Iwata, J.B. Lombardini and T. Segawa, eds, Kluwer Academic Press, Boston/Dordrecht/London, 75–97 (1989).
D.S. Steele, G.L. Smith and D.J. Miller, The effects of taurine on Ca2+ uptake by the sarcoplasmic reticulum and Ca2+ sensitivity of chemically skinned rat heart, J. Physiol. 422:499–511 (1990).
S. Galler, C. Hutzler and T. Haller, Effects of taurine on Ca2+ -dependent force development of skinned muscle fibre preparations, J. Exp. BioL 152:255–264 (1990).
RA. Chapman and J. Tunstall, The calcium paradox of the heart, Prog. Biophys. Molec. Biot 50:67–96 (1987).
M. Borgers, The role of calcium in the toxicity of the myocardium, Histochem. J. 13:839–848 (1981).
J.H. Kramer, J.P. Chovan and S.W. Schaffer, The effect of taurine on calcium paradox and ischemic heart failure, Am. J. Physiol 240:H238–H246 (1981).
K. Yamauchi-Takihara, J. Azuma, S. Kishimoto, S. Onishi and N. Sperelakis, Taurine prevention of calcium paradox-related damage in cardiac muscle, Biochem. Phannacol. 37:2651–2658 (1988).
H. Ohta, J. Azuma, N. Awata, T. Hamaguchi, Y. Tanaka, A. Sawamura, S. Kishimoto and N. Sperelakis, Mechanism of the protective action of taurine against isoprenaline induced myocardial damage, Cardiovasc. Res. 22:407–413 (1988).
T. Hamaguchi, J. Azuma, N. Awata, H. Ohta, K. Takihara, H. Harada, S. Kishimoto and N. Sperelakis, Reduction of doxorubicin-induced cardiotoxicity in mice by taurine, Res. Commun. Chem. Pathol. Pharmacol. 59:21–30 (1988).
Y. Ihara, K. Takahashi, H. Harada, A. Sawamura, S.W. Schaffer and J. Azuma, Taurine attenuates contracture induced by low Na+, high Ca2+ medium in perfused chick heart, this book (1992).
F. Franconi, I. Stendardi, P. Failli, R. Matucci, C. Baccaro, L. Montorsi, R. Bandinelli and A. Giotti, The protective effects of taurine on hypoxia (performed in the absence of glucose) and on reoxygenation (in the presence of glucose) in guinea-pig heart, Biochem. Pharmacol. 34:2611–2615 (1985).
A. Sawamura, N. Sperelalds and J. Azuma, Protective effect of taurine against decline of cardiac slow action potentials during hypoxia, Eur. J. Pharmacol 120:235–239 (1986).
N. Awata, J. Azuma, T. Hamaguchi, Y. Tanaka, H. Ohta, K. Takihara, H. Harada, A. Sawamura and S. Kishimoto, Acute haemodynamic effect of taurine on hearts in vivo with normal and depressed myocardial function, Cardiovasc. Res. 21:241–247 (1987).
K. Takihara, J. Azuma, N. Awata, H. Ohta, T. Hamaguchi, A. Sawamura, Y. Tanaka, S. Kishimoto and N. Sperelakis, Beneficial effect of taurine in rabbits with chronic congestive heart failure, Am. Heart. J. 112:1278–1284 (1986).
J. Azari, P. Brumbaugh and R. Huxtable, Prophylaxis by taurine in the hearts of cardiomyopathic hamsters, J. Mol. Cell. Cardiol. 12:1353–1366 (1980).
M.J. McBroom and J.D. Welty, Effects of taurine on heart calcium in the cardiomyopathic hamster, J. Mol. Cell. Cardiol. 9:853–858 (1977).
H. Harada, B.J. Cusack, R.D. Olson, W. Stroo, J. Azuma, T. Hamaguchi and S.W. Schaffer, Taurine deficiency and doxorubicin: Interaction with the cardiac sarcolemmal calcium pump, Biochem. Pharmacol. 39:745–751 (1990).
J. Azuma, A. Sawamura, N. Awata, H. Hasegawa, K. Ogura, H. Harada, H. Ohta, K. Yamauichi, S. Kishimoto, T. Yamagami, E. Ueda and T. Ishiyama, Double-blind randomized crossover trial of taurine in congestive heart failure, Cuff. Therap. Res. 34:543–557 (1983).
S. Fujimoto, H. Iwata and Y. Yoneda, Effect of taurine on responses to noradrenaline, acetylcholine and ouabain in isolated auricles from digitalized guinea pigs, Japan J. Phamtacol. 26:105–110 (1976).
M.C. Welty, J.D. Welty and M.J. McBroom, Effect of isoproterenol and taurine on heart calcium in normal and cardiomyopathic hamsters, J. Mol. Cell Cardiol. 14:353–357 (1982).
S.W. Schaffer, J.H. Kramer, W.G. Lampson, E. Kulakowski and Y. Sakane, Effect of taurine on myocardial metabolism: Role of calmodulin, in: “Sulfur Amino Acids: Biochemical and Clinical Aspects,” K. Kuriyama, R.J. Huxtable and H. Iwata, eds, Alan R. Liss, Inc., New York, 39–50 (1983).
L.S. Malchikova and E.P. Elizarova, Taurine and cAMP content in the heart, Medicina (Moscow) 1:85–89 (1981).
W.G. Lampson, J.H. Kramer and S.W. Schaffer, Potentiation of the actions of insulin by taurine, Can. J. Physiol Pharmacol. 61:457–463 (1983).
E.C. Kulakowski, J. Maturo and S.W. Schaffer, The low affinity taurine-binding protein may be related to the insulin receptor, in: “Taurine Biological Actions and Clinical Perspectives,” S.S. Oja, L. Ahtee, P. Kontro and M.K. Paasonen, eds, Alan R. Liss, Inc., New York, pp. 127–136 (1985).
F. Franconi, F. Bennardini, R. Matucci, I. Stendardi, P. Failli, S. Manzini and A. Giotti, Functional and binding evidence of taurine inhibition of a -adrenoceptor effects on guinea-pig ventricle, J. Mol. Cell CardioL 18:461–468 (1986).
T. Vislie and K. Fugelli, Cell volume regulation in flounder (Platichthkys flesus) heart muscle accompanying an alteration in plasma osmolality, Comp. Biochem. Physiol. 52A:415–418 (1975).
S.W. Schaffer, E.C. Kulakowski and J.H. Kramer, Taurine transport by reconstituted membrane vesicles, in: “Taurine in Nutrition and Neurology,” R.J. Huxtable and H. Pasantes-Morales, eds, Plenum Press, New York/London, pp. 143–160 (1982).
M. Atlas, J.J. Bahl, W. Roeske and R. Bressler, In vitro osmoregulation of taurine in fetal mouse hearts, J. Mol. Cell Cardiol. 16:311–320 (1984).
J.N. Thurston, R.E. Hauhart and E.F. Naccarato, Taurine: Possible role in osmotic regulation of mammalian heart, Science 214:1373–1374 (1981).
M.F. Crass III and J.B. Lombardini, Loss of cardiac muscle taurine after acute left ventricular ischemia, Life Sci. 21:951–958 (1977).
H. Harada, S. Allo, N. Viyuoh, J. Azuma, K Takahashi and S.W. Schaffer, Regulation of calcium transport in drug-induced taurine-depleted hearts, Biochim. Biophys. Acta 944:273–278 (1988).
S.W. Schaffer, S. Allo, H. Harada, W. Stroo, J. Azuma and T. Hamaguchi, Mechanism underlying the membrane stabilizing activity of taurine, in: “Taurine and the Heart,” H. Iwata, J.B. Lombardini and T. Segawa, eds, Kluwer Academic Publishers, Boston/Dordrecht/London, pp. 43–50 (1989).
J.B. Lombardini and S.M. Liebowitz, Taurine modifies calcium ion uptake and protein phosphorylation in rat heart, in: “Taurine and the Heart,” H. Iwata, J.B. Lombardini and T. Segawa, eds, Kluwer Academic Publishers, Boston/Dordrecht/London, pp. 117–137 (1989).
Y-P Li and J.B. Lombardini, Taurine inhibits protein kinase C-catalyzed phosphorylation of specific proteins in a rat cortical P2 fraction, J. Neurochem. 56:1747–1753 (1991).
S.S. Smith and J. Li, GABA receptor stimulation by baclofen and taurine enhances excitatory amino acid induced phosphatidylinositol turnover in neonatal rat cerebellum, Neurosci. Lett. 132:59–64 (1991).
K. Kuriyama, T. Hashimoto, M. Kimoti, Y. Nakamura and S-I Yamamoto, Taurine and receptor mechanisms in the heart: Possible correlates with the occurrence of ischemic myocardial damages, in: “Taurine and the Heart,” H. Iwata, J.B. Lombardini and T. Segawa, eds, Kluwer Academic Publishers, Boston/Dordrecht/London, pp. 139–158 (1989).
T. Hamaguchi, J. Azuma and S. Schaffer, Interaction of taurine with methionine: Inhibition of myocardial phospholipid methyltransferase, J. Cardiovasc. Pharmacol. 18:224–230 (1991).
M.P. Gupta, V. Panagia and N.S. Dhalla, Phospholipid N-methylation-dependent alterations of cardiac contractile function by L-methionine, J. Pharmacol. Exp. Therap. 245:664–672 (1988).
P. Dolara, A. Agresti, A. Giotti and G. Pasquini, Effect of taurine on calcium kinetics of guinea-pig heart, Eur. J. Phannacol. 24:352–358 (1973).
P. Dolara, A. Agresti, A. Giotti and E. Sorace, The effect of taurine on calcium exchange of sarcoplasmic reticulum of guinea pig heart studied by means of dialysis kinetics, Can. J. PhysioL Pharmacol. 54:529–533 (1976).
J.P. Chovan, E.C. Kulakowski, B.W. Benson and S.W. Schaffer, Taurine enhancement of calcium binding to rat heart sarcolemma, Biochim. Biophys. Acta 551:129–136 (1979).
K. Takahashi, H. Harada, S.W. Schaffer and J. Azuma, Effect of taurine on intracellular calcium dynamics of cultured myocardial cells during the calcium paradox, this book
G. Jasmin and L. Proshek, Hereditary polymyopathy and cardiomyopathy in the Syrian hamster: I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line, Muscle Nerve 5:20–25 (1982).
M. Bond, A-R Jaraki, C.H. Disch and B.P. Healy, Subcellular calcium content in cardiomyopathic hamster hearts in vivo: An electron probe study, Circ. Res. 64:1001–1012 (1989).
J. Wikman-Coffelt, T. Stefenelli, S.T. Wu, W.W. Parmley and G. Jasmin, [Ca2+] transients in the cardiomyopathic hamster heart, Circ. Res. 68:45–51 (1991).
J.T. Whitmer, P. Kumar and R.J. Solaro, Calcium transport properties of cardiac sarcoplasmic reticulum from cardiomyopathic Syrian hamsters (BIO 53.58 and 14.6): Evidence for a quantiative defect in dilated myopathic hearts not evident in hypertrophic hearts, Circ. Res. 62:81–85 (1988).
N. Makin, G. Jasmin, R.E. Beamish and N.S. Dhalla, Sarcolemmal Na+ -Ca2+ exchange during the development of genetically determined cardiomyopathy, Biochem. Biophys. Res. Commun. 133:491–497 (1985).
S.M. Factor, S. Cho, J. Scheuer, E.H. Sonnenblick and A. Malhotra, Prevention of hereditary cardiomyopathy in the Syrian hamster with chronic verapamil therapy, J. Am. Coll. Cardiol. 12:1599–1604 (1988).
J.M. Capasso, E.H. Sonnenblick and P. Anversa, Chronic calcium channel blockade prevents the progression of myocardial contractile and electrical dysfunction in the cardiomyopathic Syrian hamster, Circ. Res. 67:1381–1393 (1990).
M.J. McBroom and J.D. Welty, Effects of taurine and verapamil on heart calcium in hamsters and rats, Comp. Biochem. Physiol. 82C:279–281 (1985).
J.D. Welty and M.C. Welty, Effects of taurine on subcellular calcium dynamics in the normal and cardiomyopathic hamster heart, in: “The Effects of Taurine on Excitable Tissues,” S.W. Schaffer, S.I. Baskin and J.J. Kocsis, eds, Spectrum Publications, New York, pp. 295–312 (1981).
S.W. Schaffer, P. Punna, J. Duan, H. Harada, T. Hamaguchi and J. Azuma, Mechanism underlying physiological modulation of myocardial contraction by taurine, this book (1992).
A. Sawamura, N. Sperelakis, J. Azuma and S. Kishimoto, Effects of taurine on the electrical and mechanical activities of embryonic chick heart, Can. J. PhysioL Pharmacol. 64:649–655 (1986).
N. Sperelakis, T. Yamamoto, G. Bkaily, H. Sada, A. Sawamura and J. Azuma, Taurine effects on action potentials and ionic currents in chick myocardial cells, in: “Taurine and the Heart,” H. Iwata, J.B. Lombardini and T. Segawa, eds, Kluwer Academic Publications, Boston/Dordrecht/London, pp. 1–19 (1989).
M.L. Entman, E.P. Bornet and R. Bressler, The effect of taurine on sarcoplasmic reticulum, Life Sci. 21:543–550 (1977).
M.A. Remtulla, S. Katz and D.A. Applegarth, Effect of taurine on ATP-dependent calcium transport in guinea-pig cardiac muscle, Life Sci. 23:383–390 (1978).
E. Kulakowski, J. Maturo and S.W. Schaffer, Identification of taurine binding receptors from rat heart sarcolemma, Biochem. Biophys. Res. Commun. 80:936–941 (1978).
E.C. Kulakowski, J. Maturo and S.W. Schaffer, Solubilization and characterization of cardiac sarcolemmal taurine binding proteins, Arch. Biochem. Biophys. 210:204–209 (1981).
T. Segawa, Y. Nomura and I. Shimazaki, Possible involvement of calmodulin in modulatory role of taurine in rat cerebral B-adrenergic neurons, in: “Taurine: Biological Actions and Clinical Perspectives,” S.S. Oja, L. Ahtee, P. Kontro and M.K. Paasonen, eds, Alan R. Liss, Inc, New York, pp. 321–330 (1985).
S.W. Schaffer, S. Allo, H. Harada and J. Azuma, Regulation of calcium homeostasis by taurine: Role of calmodulin, in: “Taurine: Functional Neurochemistry, Physiology and Cardiology,” H. Pasantes-Morales, D.L. Martin, W. Shain and R.M. Del Rio, eds, Wiley-Liss, New York, pp. 217–225 (1990).
J. Maturo and E.C. Kulakowski, Insulin-like activity of taurine, in: “The Biology of Taurine: Methods and Mechanisms,” R.J. Huxtable, F. Franconi and A. Giotti, eds, Plenum Press, New York, pp. 217–226 (1987).
L.A. Sebring and R.J. Huxtable, Low affinity binding of taurine to phospholiposomes and cardiac sarcolemma, Biochim. Biophys. Acta 884:559–566 (1986).
R.J. Huxtable and L.A. Sebring, Taurine and the heart: The phospholipid connection, in: “Taurine and the Heart,” H. Iwata, J.B. Lombardini and T. Segawa, eds, Kluwer Academic Publishers, Boston/Dordrecht/London, pp. 31–42 (1989).
L.A. Sebring and R.J. Huxtable, Taurine modulation of calcium binding to cardiac sarcolemma, J. Pharmacol. Exp. Therap. 232:445–451 (1985).
R.J. Huxtable and L.A. Sebring, Towards a unifying theory for the action of taurine, Trends Pharmacol. Sci. 7:481–485 (1986).
R.J. Huxtable, From heart to hypothesis: A mechanism for the calcium modulatory actions of taurine, in: “The Biology of Taurine: Methods and Mechanisms,” R.J. Huxtable, F. Franconi and A. Giotti, eds, Plenum Press, New York, pp. 371–387 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schaffer, S.W., Azuma, J. (1992). Review: Myocardial Physiological Effects of Taurine and Their Significance. In: Lombardini, J.B., Schaffer, S.W., Azuma, J. (eds) Taurine. Advances in Experimental Medicine and Biology, vol 315. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3436-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3436-5_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6520-4
Online ISBN: 978-1-4615-3436-5
eBook Packages: Springer Book Archive